{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T03:14:44Z","timestamp":1774581284819,"version":"3.50.1"},"reference-count":45,"publisher":"Radcliffe Medical Media Ltd","license":[{"start":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T00:00:00Z","timestamp":1697587200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/legalcode"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Cardiol"],"abstract":"<jats:p>Lingering cardiac symptoms are increasingly recognised complications of severe acute respiratory syndrome coronavirus 2 infection, now referred to as post-acute cardiovascular sequelae of COVID-19 (PASC). In the acute phase, cardiac injury is driven by cytokine release and stems from ischaemic and thrombotic complications, resulting in myocardial necrosis. Patients with pre-existing cardiac conditions are particularly vulnerable. Myocarditis due to a direct viral infection is rare. Chronic symptoms relate to either worsening of pre-existing heart disease (PASC \u2013 cardiovascular disease) or delayed chronic inflammatory condition due to heterogenous immune dysregulation (PASC \u2013 cardiovascular syndrome), the latter affecting a broad segment of previously well people. Both PASC presentations are associated with increased cardiovascular risk, long-term disability and reduced quality of life. The recognition and management of PASC in clinical settings remains a considerable challenge. Sensitive diagnostic methods are needed to detect subtler inflammatory changes that underlie the persistent symptoms in PASC \u2013 cardiovascular syndrome, alongside considerable clinical experience in inflammatory cardiac conditions.<\/jats:p>","DOI":"10.15420\/ecr.2023.02","type":"journal-article","created":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T11:22:39Z","timestamp":1697714559000},"source":"Crossref","is-referenced-by-count":13,"title":["Cardiac Involvement Due to COVID-19: Insights from Imaging and Histopathology"],"prefix":"10.15420","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6044-7002","authenticated-orcid":false,"given":"Valentina O","family":"Puntmann","sequence":"first","affiliation":[{"name":"Institute for Experimental and Translational Cardiovascular Imaging, DZHK Centre for Cardiovascular Imaging, Goethe University Frankfurt, Frankfurt am Main, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8220-0350","authenticated-orcid":false,"given":"Anastasia","family":"Shchendrygina","sequence":"additional","affiliation":[{"name":"Institute for Experimental and Translational Cardiovascular Imaging, DZHK Centre for Cardiovascular Imaging, Goethe University Frankfurt, Frankfurt am Main, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5491-2529","authenticated-orcid":false,"given":"Carlos","family":"Rodriguez Bolanos","sequence":"additional","affiliation":[{"name":"Institute for Experimental and Translational Cardiovascular Imaging, DZHK Centre for Cardiovascular Imaging, Goethe University Frankfurt, Frankfurt am Main, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2681-9706","authenticated-orcid":false,"given":"Mame Madjigu\u00e8ne","family":"Ka","sequence":"additional","affiliation":[{"name":"Institute for Experimental and Translational Cardiovascular Imaging, DZHK Centre for Cardiovascular Imaging, Goethe University Frankfurt, Frankfurt am Main, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6252-4390","authenticated-orcid":false,"given":"Silvia","family":"Valbuena","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Hospital La Paz, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8771-297X","authenticated-orcid":false,"given":"Andreas","family":"Rolf","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Campus Kerckhoff of Justus-Liebig-University Giessen, Bad Nauheim, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0678-5681","authenticated-orcid":false,"given":"Felicitas","family":"Escher","sequence":"additional","affiliation":[{"name":"Institute of Cardiac Diagnostics and Therapy, IKDT GmbH, Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6044-950X","authenticated-orcid":false,"given":"Eike","family":"Nagel","sequence":"additional","affiliation":[{"name":"Institute for Experimental and Translational Cardiovascular Imaging, DZHK Centre for Cardiovascular Imaging, Goethe University Frankfurt, Frankfurt am Main, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6096","published-online":{"date-parts":[[2023,10,18]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol 2023;21:133\u201346. https:\/\/doi.org\/10.1038\/s41579-022-00846-2; PMID:\u00a036639608.","DOI":"10.1038\/s41579-022-00846-2"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Bowe B, Xie Y, Al-Aly Z. Acute and postacute sequelae associated with SARS-CoV-2 reinfection. Nat Med 2022;28:2398\u2013405. https:\/\/doi.org\/10.1038\/s41591-022-02051-3; PMID:\u00a036357676.","DOI":"10.1038\/s41591-022-02051-3"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Writing Committee; Gluckman TJ, Bhave NM, et al. 2022 ACC expert consensus decision pathway on cardiovascular sequelae of COVID-19 in adults: myocarditis and other myocardial involvement, post-acute sequelae of SARS-CoV-2 infection, and return to play: a report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol 2022;79:1717\u201356. https:\/\/doi.org\/10.1016\/j.jacc.2022.02.003; PMID:\u00a035307156.","DOI":"10.1016\/j.jacc.2022.02.003"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Hendren NS, Drazner MH, Bozkurt B, Cooper LT. Description and proposed management of the acute COVID-19 cardiovascular syndrome. Circulation 2020;141:1903\u201314. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.047349; PMID:\u00a032297796.","DOI":"10.1161\/circulationaha.120.047349"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Puntmann VO, Martin S, Shchendrygina A, et al. Long-term cardiac pathology in individuals with mild initial COVID-19 illness. Nat Med 2022;28:2117\u201323. https:\/\/doi.org\/10.1038\/s41591-022-02000-0; PMID:\u00a036064600.","DOI":"10.1038\/s41591-022-02000-0"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Gordon JS, Drazner MH. Biomarkers of cardiac stress and cytokine release syndrome in COVID-19: a review. Curr Heart Fail Rep 2021;18:163\u20138. https:\/\/doi.org\/10.1007\/s11897-021-00505-2; PMID:\u00a033666855.","DOI":"10.1007\/s11897-021-00505-2"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Libby P, L\u00fcscher T. COVID-19 is, in the end, an endothelial disease. Eur Heart J 2020;41:3038\u201344. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa623; PMID:\u00a032882706.","DOI":"10.1093\/eurheartj\/ehaa623"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Hudowenz O, Klemm P, Lange U, et al. Case report of severe PCR-confirmed COVID-19 myocarditis in a European patient manifesting in mid January 2020. Eur Heart J Case Rep 2020;4:1\u20136. https:\/\/doi.org\/10.1093\/ehjcr\/ytaa286; PMID:\u00a033437916.","DOI":"10.1093\/ehjcr\/ytaa286"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Tanacli R, Doeblin P, G\u00f6tze C, et al. COVID-19 vs. classical myocarditis associated myocardial injury evaluated by cardiac magnetic resonance and endomyocardial biopsy. Front Cardiovasc Med 2021;8:737257. https:\/\/doi.org\/10.3389\/fcvm.2021.737257; PMID:\u00a035004872.","DOI":"10.3389\/fcvm.2021.737257"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Halushka MK, Vander Heide RS. Myocarditis is rare in COVID-19 autopsies: cardiovascular findings across 277 postmortem examinations. Cardiovasc Pathol 2021;50:107300.  https:\/\/doi.org\/10.1016\/j.carpath.2020.107300; PMID:\u00a033132119.","DOI":"10.1016\/j.carpath.2020.107300"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Pellegrini D, Kawakami R, Guagliumi G, et al. Microthrombi as a major cause of cardiac injury in COVID-19: a pathologic study. Circulation 2021;143:1031\u201342. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.051828; PMID:\u00a033480806.","DOI":"10.1161\/CIRCULATIONAHA.120.051828"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Basso C, Leone O, Rizzo S, et al. Pathological features of COVID-19-associated myocardial injury: a multicentre cardiovascular pathology study. Eur Heart J 2020;41:3827\u201335. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa664; PMID:\u00a032968776.","DOI":"10.1093\/eurheartj\/ehaa664"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature 2021;594:259\u201364. https:\/\/doi.org\/10.1038\/s41586-021-03553-9; PMID:\u00a033887749.","DOI":"10.1038\/s41586-021-03553-9"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Sudre CH, Murray B, Varsavsky T, et al. Attributes and predictors of long COVID. Nat Med 2021;27:626\u201331.https:\/\/doi.org\/10.1038\/s41591-021-01292-y; PMID:\u00a033692530.","DOI":"10.1038\/s41591-021-01292-y"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Satterfield BA, Bhatt DL, Gersh BJ. Cardiac involvement in the long-term implications of COVID-19. Nat Rev Cardiol 2022;19:332\u201341. https:\/\/doi.org\/10.1038\/s41569-021-00631-3; PMID:\u00a034686843.","DOI":"10.1038\/s41569-021-00631-3"},{"key":"ref15","unstructured":"Writing Committee Members; Otto CM, Nishimura RA 2021, et al. 2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines. J Thorac Cardiovasc Surg 2021;162:e183\u2013353. https:\/\/doi.org\/10.1016\/j.jtcvs.2021.04.002; PMID:\u00a033972115."},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Brito D, Meester S, Yanamala N, et al. High prevalence of pericardial involvement in college student athletes recovering from COVID-19. JACC Cardiovasc Imaging 2021;14:541\u201355. https:\/\/doi.org\/10.1016\/j.jcmg.2020.10.023; PMID:\u00a033223496.","DOI":"10.1016\/j.jcmg.2020.10.023"},{"key":"ref17","unstructured":"Daniels CJ, Rajpal S, Greenshields JT, et al. Prevalence of clinical and subclinical myocarditis in competitive athletes with recent SARS-CoV-2 infection: results from the Big Ten COVID-19 Cardiac Registry. JAMA Cardiol 2021;6:1078\u201387. https:\/\/doi.org\/10.1001\/jamacardio.2021.2065; PMID:\u00a034042947."},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Montone RA, Iannaccone G, Meucci MC, et al. Myocardial and microvascular injury due to coronavirus disease 2019. Eur Cardiol 2020;15:e52. https:\/\/doi.org\/10.15420\/ecr.2020.22; PMID:\u00a032617121.","DOI":"10.15420\/ecr.2020.22"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Mackay A. A paradigm for post-Covid-19 fatigue syndrome analogous to ME\/CFS. Front Neurol 2021;12:701419. https:\/\/doi.org\/10.3389\/fneur.2021.701419; PMID:\u00a034408721.","DOI":"10.3389\/fneur.2021.701419"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"D\u00e9cary S, Gaboury I, Poirier S, et al. Humility and acceptance: working within our limits with long COVID and myalgic encephalomyelitis\/chronic fatigue syndrome. J Orthop Sports Phys Ther 2021;51:197\u2013200. https:\/\/doi.org\/10.2519\/jospt.2021.0106; PMID:\u00a033930983.","DOI":"10.2519\/jospt.2021.0106"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Kedor C, Freitag H, Meyer-Arndt L, et al. A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity. Nat Commun 2022;13:5104. https:\/\/doi.org\/10.1038\/s41467-022-32507-6; PMID:\u00a036042189.","DOI":"10.1038\/s41467-022-32507-6"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Blomberg B, Mohn KG-I, Brokstad KA, et al. Long COVID in a prospective cohort of home-isolated patients. Nat Med 2021;27:1607\u201313. https:\/\/doi.org\/10.1038\/s41591-021-01433-3; PMID:\u00a034163090.","DOI":"10.1038\/s41591-021-01433-3"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Fairweather D, Beetler DJ, Di Florio DN, et al. COVID-19, myocarditis and pericarditis. Circ Res 2023;132:1302\u201319. https:\/\/doi.org\/10.1161\/CIRCRESAHA.123.321878; PMID:\u00a037167363.","DOI":"10.1161\/circresaha.123.321878"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Rajpal S, Tong MS, Borchers J, et al. Cardiovascular magnetic resonance findings in competitive athletes recovering from COVID-19 infection. JAMA Cardiol 2021;6:116\u20138. https:\/\/doi.org\/10.1001\/jamacardio.2020.4916; PMID:\u00a032915194.","DOI":"10.1001\/jamacardio.2020.4916"},{"key":"ref25","unstructured":"Moulson N, Petek BJ, Drezner JA, et al. SARS-CoV-2 cardiac involvement in young competitive athletes. Circulation 2021;144:256\u201366. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.121.054824; PMID:\u00a033866822."},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Dahl\u00f6f B, Devereux RB, Kjeldsen SE, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002;359:995\u20131003. https:\/\/doi.org\/10.1016\/S0140-6736(02)08089-3; PMID:\u00a011937178.","DOI":"10.1016\/s0140-6736(02)08089-3"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Brenner BM, Cooper ME, de Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001;345:861\u20139. https:\/\/doi.org\/10.1056\/NEJMoa011161; PMID:\u00a011565518.","DOI":"10.1056\/nejmoa011161"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Puntmann VO, D\u2019Cruz D, Smith Z, et al. Native myocardial T1 mapping by cardiovascular magnetic resonance imaging in subclinical cardiomyopathy in patients with systemic lupus erythematosus. Circ Cardiovasc Imaging 2013;6:295\u2013301. https:\/\/doi.org\/10.1161\/CIRCIMAGING.112.000151; PMID:\u00a023403334.","DOI":"10.1161\/circimaging.112.000151"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Mavrogeni S, Koutsogeorgopoulou L, Markousis-Mavrogenis G, et al. Cardiovascular magnetic resonance detects silent heart disease missed by echocardiography in systemic lupus erythematosus. Lupus 2018;27:564\u201371. https:\/\/doi.org\/10.1177\/0961203317731533; PMID:\u00a028927316.","DOI":"10.1177\/0961203317731533"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Ishimori ML, Martin R, Berman DS, et al. Myocardial ischemia in the absence of obstructive coronary artery disease in systemic lupus erythematosus. JACC Cardiovasc Imaging 2011;4:27\u201333. https:\/\/doi.org\/10.1016\/j.jcmg.2010.09.019; PMID:\u00a021232700.","DOI":"10.1016\/j.jcmg.2010.09.019"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Hachulla AL, Launay D, Gaxotte V, et al. Cardiac magnetic resonance imaging in systemic sclerosis: a cross-sectional observational study of 52 patients. Ann Rheum Dis 2009;68:1878\u201384. https:\/\/doi.org\/10.1136\/ard.2008.095836; PMID:\u00a019054830.","DOI":"10.1136\/ard.2008.095836"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Rodriguez-Reyna TS, Morelos-Guzman M, Hernandez-Reyes P, et al. Assessment of myocardial fibrosis and microvascular damage in systemic sclerosis by magnetic resonance imaging and coronary angiotomography. Rheumatology (Oxford) 2015;54:647\u201354. https:\/\/doi.org\/10.1093\/rheumatology\/keu350; PMID:\u00a025239881.","DOI":"10.1093\/rheumatology\/keu350"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Pankuweit S, Klingel K. Viral myocarditis: from experimental models to molecular diagnosis in patients. Heart Fail Rev 2013;18:683\u2013702. https:\/\/doi.org\/10.1007\/s10741-012-9357-4; PMID:\u00a023070541.","DOI":"10.1007\/s10741-012-9357-4"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Holloway CJ, Ntusi N, Suttie J, et al. Comprehensive cardiac magnetic resonance imaging and spectroscopy reveal a high burden of myocardial disease in HIV patients. Circulation 2013;128:814\u201322. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.113.001719; PMID:\u00a023817574.","DOI":"10.1161\/circulationaha.113.001719"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"Leuw P de, Arendt CT, Haberl AE, et al. Myocardial fibrosis and inflammation by CMR predict cardiovascular outcome in people living with HIV. JACC Cardiovasc Imaging 2021;14:1548\u201357. https:\/\/doi.org\/10.1016\/j.jcmg.2021.01.042; PMID:\u00a033865770.","DOI":"10.1016\/j.jcmg.2021.01.042"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Komaroff AL, Lipkin WI. Insights from myalgic encephalomyelitis\/chronic fatigue syndrome may help unravel the pathogenesis of postacute COVID-19 syndrome. Trends Mol Med 2021;27:895\u2013906. https:\/\/doi.org\/10.1016\/j.molmed.2021.06.002; PMID:\u00a034175230.","DOI":"10.1016\/j.molmed.2021.06.002"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"Winau L, Baydes RH, Braner A, et al. High-sensitive troponin is associated with subclinical imaging biosignature of inflammatory cardiovascular involvement in systemic lupus erythematosus. Ann Rheum Dis 2018;77:1590\u20138. https:\/\/doi.org\/10.1136\/annrheumdis-2018-213661; PMID:\u00a030077990.","DOI":"10.1136\/annrheumdis-2018-213661"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Puntmann VO, Peker E, Chandrashekhar Y, Nagel E. T1 mapping in characterizing myocardial disease: a comprehensive review. Circ Res 2016;119:277\u201399. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.307974; PMID:\u00a027390332.","DOI":"10.1161\/circresaha.116.307974"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"Augustine DX, Keteepe-Arachi T, Malhotra A. Coronavirus disease 2019: cardiac complications and considerations for returning to sports participation. Eur Cardiol 2021;16:e03. https:\/\/doi.org\/10.15420\/ecr.2020.36; PMID:\u00a033708264.","DOI":"10.15420\/ecr.2020.36"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"Mart\u00ednez-Rubio A, Ascoeta S, Taibi F, Soldevila JG. Coronavirus disease 2019 and cardiac arrhythmias. Eur Cardiol 2020;15:e66. https:\/\/doi.org\/10.15420\/ecr.2020.23; PMID:\u00a033294034.","DOI":"10.15420\/ecr.2020.23"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"Coto E, Avanzas P, G\u00f3mez J. The renin\u2013angiotensin\u2013aldosterone system and coronavirus disease 2019. Eur Cardiol 2021;16:e07. https:\/\/doi.org\/10.15420\/ecr.2020.30; PMID:\u00a033737961.","DOI":"10.15420\/ecr.2020.30"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"South AM, Brady TM, Flynn JT. ACE2 (angiotensin-converting enzyme 2), COVID-19, and ACE inhibitor and Ang II (angiotensin II) receptor blocker use during the pandemic: the pediatric perspective. Hypertension 2020;76:16\u201322. https:\/\/doi.org\/10.1161\/hypertensionaha.120.15291; PMID:\u00a032367746.","DOI":"10.1161\/hypertensionaha.120.15291"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"Rey JR, Caro-Cod\u00f3n J, Rosillo SO, et al. Heart failure in COVID-19 patients: prevalence, incidence and prognostic implications. Eur J Heart Fail 2020;22:2205\u201315. https:\/\/doi.org\/10.1002\/ejhf.1990; PMID:\u00a032833283.","DOI":"10.1002\/ejhf.1990"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"Laverman GD, Remuzzi G, Ruggenenti P. ACE inhibition versus angiotensin receptor blockade: which is better for renal and cardiovascular protection? J Am Soc Nephrol 2004;15(Suppl 1):S64\u201370. https:\/\/doi.org\/10.1097\/01.asn.0000093368.27046.3c; PMID:\u00a014684676.","DOI":"10.1097\/01.asn.0000093368.27046.3c"}],"container-title":["European Cardiology Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ecrjournal.com\/articleindex\/ecr.2023.02","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T11:23:10Z","timestamp":1697714590000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ecrjournal.com\/articleindex\/ecr.2023.02"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,18]]},"references-count":45,"URL":"https:\/\/doi.org\/10.15420\/ecr.2023.02","relation":{},"ISSN":["1758-3764","1758-3756"],"issn-type":[{"value":"1758-3764","type":"electronic"},{"value":"1758-3756","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,18]]},"article-number":"e58"}}